REEP1
Basic information
Region (hg38): 2:86213993-86338083
Previous symbols: [ "C2orf23" ]
Links
Phenotypes
GenCC
Source:
- neuronopathy, distal hereditary motor, type 5B (Limited), mode of inheritance: AD
- hereditary spastic paraplegia 31 (Definitive), mode of inheritance: AD
- hereditary spastic paraplegia 31 (Supportive), mode of inheritance: AD
- neuronopathy, distal hereditary motor, type 5A (Supportive), mode of inheritance: AD
- spinal muscular atrophy, distal, autosomal recessive, 6 (Limited), mode of inheritance: AR
- neuronopathy, distal hereditary motor, type 5B (Strong), mode of inheritance: AD
- hereditary spastic paraplegia 31 (Strong), mode of inheritance: AD
- spinal muscular atrophy, distal, autosomal recessive, 6 (Limited), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Spastic paraplegia 31, autosomal dominant; Neuronopathy, distal hereditary motor, autosomal dominant 12; Neuronopathy, distal hereditary motor, autosomal recessive 6 | AD/AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Neurologic | 16826527; 18321925; 19034539; 22703882; 27066569; 31872057; 34193129 |
ClinVar
This is a list of variants' phenotypes submitted to
- Hereditary spastic paraplegia 31 (30 variants)
- not provided (9 variants)
- Hereditary spastic paraplegia (4 variants)
- Charcot-Marie-Tooth disease (1 variants)
- Neuronopathy, distal hereditary motor, type 5B (1 variants)
- Inborn genetic diseases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the REEP1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 31 | 33 | ||||
missense | 102 | 115 | ||||
nonsense | 10 | 14 | ||||
start loss | 1 | |||||
frameshift | 15 | 25 | ||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 16 | |||||
splice region | 1 | 12 | 9 | 22 | ||
non coding | 43 | 48 | 45 | 137 | ||
Total | 38 | 25 | 151 | 81 | 47 |
Highest pathogenic variant AF is 0.00000657
Variants in REEP1
This is a list of pathogenic ClinVar variants found in the REEP1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-86214044-A-G | Hereditary spastic paraplegia 31 | Likely benign (Jun 29, 2018) | ||
2-86214072-G-C | Hereditary spastic paraplegia 31 | Uncertain significance (Jan 13, 2018) | ||
2-86214143-G-A | Hereditary spastic paraplegia 31 | Uncertain significance (Jan 12, 2018) | ||
2-86214180-A-C | Hereditary spastic paraplegia 31 | Benign (Jun 29, 2018) | ||
2-86214189-A-C | Hereditary spastic paraplegia 31 | Uncertain significance (Jan 13, 2018) | ||
2-86214211-C-CTGTT | Spastic paraplegia, autosomal dominant | Benign (Jun 29, 2018) | ||
2-86214214-T-G | Hereditary spastic paraplegia 31 | Benign (Dec 01, 2021) | ||
2-86214255-C-T | Hereditary spastic paraplegia 31 | Benign (Jan 13, 2018) | ||
2-86214273-A-G | Hereditary spastic paraplegia 31 | Benign (Apr 27, 2017) | ||
2-86214306-T-G | Hereditary spastic paraplegia 31 | Uncertain significance (Jan 13, 2018) | ||
2-86214460-A-G | Hereditary spastic paraplegia 31 | Likely benign (Apr 27, 2017) | ||
2-86214481-T-C | Hereditary spastic paraplegia 31 | Uncertain significance (Jan 13, 2018) | ||
2-86214526-C-T | Hereditary spastic paraplegia 31 | Likely benign (Mar 03, 2020) | ||
2-86214554-C-T | Hereditary spastic paraplegia 31 | Benign (Jan 13, 2018) | ||
2-86214582-C-G | Hereditary spastic paraplegia 31 | Benign/Likely benign (Jul 02, 2019) | ||
2-86214605-C-G | Hereditary spastic paraplegia 31 | Uncertain significance (Jan 13, 2018) | ||
2-86214659-G-A | Hereditary spastic paraplegia 31 | Uncertain significance (Jan 13, 2018) | ||
2-86214682-T-C | Hereditary spastic paraplegia 31 | Uncertain significance (Jan 12, 2018) | ||
2-86214729-G-A | Hereditary spastic paraplegia 31 | Uncertain significance (Jan 13, 2018) | ||
2-86214839-G-T | Hereditary spastic paraplegia 31 | Uncertain significance (Jan 13, 2018) | ||
2-86214850-G-T | Hereditary spastic paraplegia 31 | Uncertain significance (Jan 13, 2018) | ||
2-86214908-C-T | Hereditary spastic paraplegia 31 | Likely benign (Jun 24, 2021) | ||
2-86214988-G-GA | Spastic paraplegia, autosomal dominant | Uncertain significance (Jun 14, 2016) | ||
2-86214989-CA-C | Likely benign (Oct 29, 2020) | |||
2-86214989-C-CA | Spastic paraplegia, autosomal dominant | Benign (Feb 13, 2020) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
REEP1 | protein_coding | protein_coding | ENST00000538924 | 7 | 124091 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.986 | 0.0137 | 125716 | 0 | 1 | 125717 | 0.00000398 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.35 | 80 | 122 | 0.655 | 0.00000725 | 1334 |
Missense in Polyphen | 15 | 33.103 | 0.45313 | 374 | ||
Synonymous | -0.331 | 52 | 49.0 | 1.06 | 0.00000341 | 406 |
Loss of Function | 3.34 | 0 | 13.0 | 0.00 | 6.47e-7 | 149 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00000879 | 0.00000879 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Required for endoplasmic reticulum (ER) network formation, shaping and remodeling; it links ER tubules to the cytoskeleton. May also enhance the cell surface expression of odorant receptors (PubMed:20200447). May play a role in long-term axonal maintenance (PubMed:24478229). {ECO:0000269|PubMed:20200447, ECO:0000269|PubMed:24478229}.;
- Disease
- DISEASE: Neuronopathy, distal hereditary motor, 5B (HMN5B) [MIM:614751]: A disorder characterized by distal muscular atrophy mainly affecting the upper extremities, in contrast to other distal motor neuronopathies. These constitute a heterogeneous group of neuromuscular diseases caused by selective degeneration of motor neurons in the anterior horn of the spinal cord, without sensory deficit in the posterior horn. The overall clinical picture consists of a classical distal muscular atrophy syndrome in the legs without clinical sensory loss. The disease starts with weakness and wasting of distal muscles of the anterior tibial and peroneal compartments of the legs. Later on, weakness and atrophy may expand to the proximal muscles of the lower limbs and/or to the distal upper limbs. HMN5B is characterized by onset in the first or second decade of distal muscle weakness and atrophy, primarily affecting the intrinsic hand muscles, but also affecting the lower legs, resulting in abnormal gait and pes cavus. {ECO:0000269|PubMed:22703882}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Signaling by GPCR;Signal Transduction;Olfactory Signaling Pathway;G alpha (s) signalling events;GPCR downstream signalling
(Consensus)
Recessive Scores
- pRec
- 0.112
Intolerance Scores
- loftool
- 0.107
- rvis_EVS
- 0.17
- rvis_percentile_EVS
- 65.56
Haploinsufficiency Scores
- pHI
- 0.442
- hipred
- Y
- hipred_score
- 0.773
- ghis
- 0.431
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0542
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Reep1
- Phenotype
- behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); skeleton phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); cellular phenotype; homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- regulation of intracellular transport;protein insertion into membrane;endoplasmic reticulum tubular network organization
- Cellular component
- cytoplasm;endoplasmic reticulum;endoplasmic reticulum membrane;membrane;integral component of membrane;mitochondrial membrane;endoplasmic reticulum tubular network
- Molecular function
- protein binding;microtubule binding;olfactory receptor binding